Fengbiao Zhou
Has grant
Group leader
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
The functional role of snoRNAs in NPM1 wildtype and mutant AML
Open Date:
Close Date:
Articles (8)
Year:
2026
SnoRNAs are highly expressed in AML and play a role in leukemogenesis and leukemic maintenance. SnoRNAs can be further processed into snoRNA-derived RNAs (sdRNAs). Expression and implications of sdRNAs in AML and healthy hematopoiesis, however, remain largely elusive. We characterized sdRNA and snoRNA levels in hematopoietic stem cells (HSCs), healthy peripheral blood cells, and 159 AML patient samples at initial diagnosis. HSCs, healthy WBCs and AML blasts could be differentiated by their sdRNA expression pattern in a cell-type specific manner. In AML, high sd3’-RNA/snoRNA-hostgene ratios were associated with inverse patient outcome. Particularly, in NPM1-mutated patients with favorable risk stratification and good initial therapy response, high sd3’-RNA ratios identified a subgroup with inferior outcome, and could therefore represent biomarkers to identify those at-risk patients. High sd3’-RNA ratios were associated with clear alterations in oncogenic, inflammatory and immune response signalling. Forced expression of single sdRNAs, such as sd3’-SNORD78 and sd5’-SNORD93, enhanced clonogenic potential in AML. Total proteome and transcriptome analyses suggested NUDT21, a reported tumor suppressor with implications in inflammatory and immune response signalling, as novel target of sd3’-SNORD78. Our data introduces sdRNAs as effector molecules in healthy hematopoiesis and AML with mechanistic, diagnostic, as well as potential prognostic and therapeutic implications.
Year:
2026
Supplementary Figure S1 shows enrichment of FBL in LSC, correlation of FBL with LSC signature and rRNA 2'-O-Me in healthy hematopoietic cells. Supplementary Figure S2 shows the association of rRNA 2’-O-Me with LSC and hematopoietic differentiation signatures. Supplementary Figure S3 shows strategy for LSC sorting and distribution of LSC methylation sites on ribosomes. Supplementary Figure S4 shows the effect of FBL knockdown on rRNA 2’-O-methylation and in vitro proliferation of leukemia cells. Supplementary Figure S5 show the effect of FBL overexpression on in vivo engraftment of primary AML cells. Supplementary Figure S6 shows the effect of FBL knockdown on nascent proteome and metabolism of AML cells. Supplementary Figure S7 shows the ribosome footprinting analysis after FBL knockdown. Supplementary Figure S8 shows the association of Gm1447 with LSC signature and the effect of Gm1447 supression on cellular amino acid levels. Supplementary Figure S9 shows regulatory effect of Gm1447 on in vivo leukemic self-renewal.
Year:
2025
Supplementary table S1 shows all rRNA 2’-O-methylation sites identified in human AMLs. Supplementary table S2 shows dynamic rRNA 2’-O-methylation sites in each DyMeC cluster. Supplementary table S3 shows the location of rRNA 2’-O-methylation static sites in ribosome regions. Supplementary table S4 shows proteins with altered translation after FBL knockdown.
Year:
2025
The development and regulation of malignant self-renewal remain unresolved issues. Here, we provide biochemical, genetic, and functional evidence that dynamics in ribosomal RNA (rRNA) 2′-O-methylation regulate leukemia stem cell (LSC) activity in vivo . A comprehensive analysis of the rRNA 2′-O-methylation landscape of 94 patients with acute myeloid leukemia (AML) revealed dynamic 2′-O-methylation specifically at exterior sites of ribosomes. The rRNA 2′-O-methylation pattern is closely associated with AML development stage and LSC gene expression signature. Forced expression of the 2′-O-methyltransferase fibrillarin (FBL) induced an AML stem cell phenotype and enabled engraftment of non-LSC leukemia cells in NSG mice. Enhanced 2′-O-methylation redirected the ribosome translation program toward amino acid transporter mRNAs enriched in optimal codons and subsequently increased intracellular amino acid levels. Methylation at the single site 18S-guanosine 1447 was instrumental for LSC activity. Collectively, our work demonstrates that dynamic 2′-O-methylation at specific sites on rRNAs shifts translational preferences and controls AML LSC self-renewal. Significance: We establish the complete rRNA 2′-O-methylation landscape in human AML. Plasticity of rRNA 2′-O-methylation shifts protein translation toward an LSC phenotype. This dynamic process constitutes a novel concept of how cancers reprogram cell fate and function. This article is highlighted in the In This Issue feature, p. 247
Year:
2025
RNA constitutes a large fraction of chromatin. Spatial distribution and functional relevance of most of RNA-chromatin interactions remain unknown. We established a landscape analysis of RNA-chromatin interactions in human acute myeloid leukemia (AML). In total more than 50 million interactions were captured in an AML cell line. Protein-coding mRNAs and long non-coding RNAs exhibited a substantial number of interactions with chromatin in cis suggesting transcriptional activity. In contrast, small nucleolar RNAs (snoRNAs) and small nuclear RNAs (snRNAs) associated with chromatin predominantly in trans suggesting chromatin specific functions. Of note, snoRNA-chromatin interaction was associated with chromatin modifications and occurred independently of the classical snoRNA-RNP complex. Two C/D box snoRNAs, namely SNORD118 and SNORD3A , displayed high frequency of trans -association with chromatin. The transcription of SNORD118 and SNORD3A was increased upon leukemia transformation and enriched in leukemia stem cells, but decreased during myeloid differentiation. Suppression of SNORD118 and SNORD3A impaired leukemia cell proliferation and colony forming capacity in AML cell lines and primary patient samples. Notably, this effect was leukemia specific with less impact on healthy CD34+ hematopoietic stem and progenitor cells. These findings highlight the functional importance of chromatin-associated RNAs overall and in particular of SNORD118 and SNORD3A in maintaining leukemia propagation.
Year:
2024
RNA constitutes a large fraction of chromatin. Spatial distribution and functional relevance of RNA associating with chromatin remain largely elusive. We established a landscape analysis of RNA-chromatin interactions in human acute myeloid leukemia (AML). In total more than 50 million interactions were captured in an AML cell line. Protein-coding mRNAs and long non-coding RNAs (lncRNAs) exhibited a substantial number of cis -interactions with chromatin suggesting transcriptional activity. In contrast, small nucleolar RNAs (snoRNAs) and small nuclear RNAs (snRNAs) associated with chromatin predominantly in trans indicating chromatin specific functions. Of note, snoRNA-chromatin interaction associates with chromatin modification and is independent of the classical snoRNA-RNP complexes. Two non-canonical C/D box snoRNAs, namely SNORD118 and SNORD3A , displayed high frequency of trans -association with chromatin. The transcription of SNORD118 and SNORD3A was increased upon leukemia transformation and enriched in leukemia stem cells, but decreased during myeloid differentiation. Suppression of SNORD118 and SNORD3A impaired leukemia cell proliferation and colony forming capacity in AML cells, but had minimal impact on healthy CD34+ hematopoietic stem and progenitor cells (HSPCs). These findings highlight the functional importance of chromatin-associated RNAs overall and in particular of SNORD118 and SNORD3A in maintaining leukemia propagation.
Year:
2024
Year:
2023
Collaborators (11)
Daria Fijałkowska
Staff scientists: data analyst
Vlaams Instituut voor Biotechnologie
Haiyang Yun
Group Leader
Heidelberg University
Tim Sauer
Heidelberg University
Caroline Pabst
Heidelberg University
Hubert Serve
Klinikdirektor, Professor
Goethe University Frankfurt
Maximilian Felix Blank
-
Jeroen Krijgsveld
Deutsches Krebsforschungszentrum
Michaela Frye
Professor
Deutsches Krebsforschungszentrum
Lukas John
Deutsches Krebsforschungszentrum
Thomas Oellerich
Goethe University Frankfurt
Carsten Müller-Tidow
Medical Director
University Hospital Heidelberg
Make your next move.
Prepare your application
Review drafts before you send them.